Compliance in the Cloud–and why you should care

This morning at the Drug Information Association Annual Meeting in Boston, Microsoft and our partners took the wraps off some whitepapers that at first glance would seem only applicable to techies at pharmaceutical companies.  And to some degree that is correct.  But this is important for patients as well.  So, it begs the question: why…

2

Final Call: Life Science Innovation Awards

Have you submitted your application for this years Microsoft Life Science Innovation Awards?  Do you have an innovative solution focused on bringing therapeutic breakthroughs to market faster, fight serious ailments, improve health and enhance patient’s qualify of life? Is your solution in a Life Science or related organization? Pharmaceutical Companies Biotechnology Companies Medical Device Companies…

0

Patient Centric Health & DSM-5

In this blog we frequently discuss questions around Patient Centric health, connected medical devices, medical devices in the home, medication adherence, validated instruments and etc.  But we’ve never really tackled the question of Mental Health and how to approach it from a patient centric point of view.  A statement released on April 29th by Thomas…

1

Partnering with Microsoft in the Cloud

Today’s “Monday Blog” article is brought to us by a guest author, Mohamed Ayad, with the article focusing on how to Partner with Microsoft in the Cloud.  It’s a great article, well named, and clearly positions Microsoft as a player in the cloud, with further announcements on Part 11 and GxP to come.  Read on…

0

What is ShareFEST and why should I go?

There are only a few conferences – large and small – that I go to every year.  DIA Electronic Document Management.  BioIT World.  DIA Annual Meeting.  HIMSS. But for the Life Sciences team one of the most important is ShareFEST, being held this year at the Lowes Hotel in Philadelphia on April 24th to 26th….

0

Patient Engagement for Clinical Trials–Features

As we discussed last week, over the next few weeks we’ll be looking at how Patient Engagement can effect clinical trials.  In order to move on to architecture (next week – February 4th) and the business value (February 11th), we need to discuss the required features. There are core features (architectural components?) of Patient Engagement…

0

Patient Engagement in Life Sciences–Introductory Post

Welcome to the first blog post on Patient Engagement in Life Sciences.  Over the next few posts we’ll focus on how Life Science organizations can run clinical trials that are more efficient and cost effective, while providing a better experience for the patient themselves, by engaging more deeply with the patient. The early stages of…

0